These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 16759886)
1. Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants. Trejo FM; Minnaard J; Perez PF; De Antoni GL Anaerobe; 2006 Aug; 12(4):186-93. PubMed ID: 16759886 [TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains. Schoster A; Kokotovic B; Permin A; Pedersen PD; Dal Bello F; Guardabassi L Anaerobe; 2013 Apr; 20():36-41. PubMed ID: 23471038 [TBL] [Abstract][Full Text] [Related]
3. Prebiotic-non-digestible oligosaccharides preference of probiotic bifidobacteria and antimicrobial activity against Clostridium difficile. Kondepudi KK; Ambalam P; Nilsson I; Wadström T; Ljungh A Anaerobe; 2012 Oct; 18(5):489-97. PubMed ID: 22940065 [TBL] [Abstract][Full Text] [Related]
4. Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria. Butel MJ; Roland N; Hibert A; Popot F; Favre A; Tessedre AC; Bensaada M; Rimbault A; Szylit O J Med Microbiol; 1998 May; 47(5):391-9. PubMed ID: 9879939 [TBL] [Abstract][Full Text] [Related]
5. Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro. Trejo FM; Pérez PF; De Antoni GL Antonie Van Leeuwenhoek; 2010 Jun; 98(1):19-29. PubMed ID: 20232250 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application. Cheikhyoussef A; Pogori N; Chen W; Zhang H Int J Food Microbiol; 2008 Jul; 125(3):215-22. PubMed ID: 18514343 [TBL] [Abstract][Full Text] [Related]
7. Specific Bifidobacterium strains isolated from elderly subjects inhibit growth of Staphylococcus aureus. Lahtinen SJ; Jalonen L; Ouwehand AC; Salminen SJ Int J Food Microbiol; 2007 Jun; 117(1):125-8. PubMed ID: 17462772 [TBL] [Abstract][Full Text] [Related]
8. Growth of infant faecal bifidobacteria and clostridia on prebiotic oligosaccharides in in vitro conditions. Rada V; Nevoral J; Trojanová I; Tománková E; Smehilová M; Killer J Anaerobe; 2008 Oct; 14(4):205-8. PubMed ID: 18583163 [TBL] [Abstract][Full Text] [Related]
9. Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion. Collado MC; Gueimonde M; Hernández M; Sanz Y; Salminen S J Food Prot; 2005 Dec; 68(12):2672-8. PubMed ID: 16355841 [TBL] [Abstract][Full Text] [Related]
10. Interaction of bifidobacteria with Caco-2 cells-adhesion and impact on expression profiles. Riedel CU; Foata F; Goldstein DR; Blum S; Eikmanns BJ Int J Food Microbiol; 2006 Jul; 110(1):62-8. PubMed ID: 16713644 [TBL] [Abstract][Full Text] [Related]
11. The correlation between surface hydrophobicity and adherence of Bifidobacterium strains from centenarians' faeces. Pan WH; Li PL; Liu Z Anaerobe; 2006 Jun; 12(3):148-52. PubMed ID: 16765861 [TBL] [Abstract][Full Text] [Related]
12. Competitive exclusion of enteropathogens from human intestinal mucus by Bifidobacterium strains with acquired resistance to bile--a preliminary study. Gueimonde M; Margolles A; de los Reyes-Gavilán CG; Salminen S Int J Food Microbiol; 2007 Jan; 113(2):228-32. PubMed ID: 16842877 [TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study. Fredua-Agyeman M; Stapleton P; Basit AW; Beezer AE; Gaisford S Int J Pharm; 2017 Jan; 517(1-2):96-103. PubMed ID: 27923699 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of adhesion properties and antibacterial activities of the infant gut commensal Bifidobacterium bifidum PRL2010. Serafini F; Strati F; Ruas-Madiedo P; Turroni F; Foroni E; Duranti S; Milano F; Perotti A; Viappiani A; Guglielmetti S; Buschini A; Margolles A; van Sinderen D; Ventura M Anaerobe; 2013 Jun; 21():9-17. PubMed ID: 23523946 [TBL] [Abstract][Full Text] [Related]
15. The role of hemagglutination and effect of exopolysaccharide production on bifidobacteria adhesion to Caco-2 cells in vitro. Alp G; Aslim B; Suludere Z; Akca G Microbiol Immunol; 2010 Nov; 54(11):658-65. PubMed ID: 21044139 [TBL] [Abstract][Full Text] [Related]
16. Real-time PCR quantification of bacterial adhesion to Caco-2 cells: competition between bifidobacteria and enteropathogens. Candela M; Seibold G; Vitali B; Lachenmaier S; Eikmanns BJ; Brigidi P Res Microbiol; 2005 Sep; 156(8):887-95. PubMed ID: 16024231 [TBL] [Abstract][Full Text] [Related]
17. Factors influencing the composition of the intestinal microbiota in early infancy. Penders J; Thijs C; Vink C; Stelma FF; Snijders B; Kummeling I; van den Brandt PA; Stobberingh EE Pediatrics; 2006 Aug; 118(2):511-21. PubMed ID: 16882802 [TBL] [Abstract][Full Text] [Related]
18. Selective growth-inhibitory effect of 8-hydroxyquinoline towards Clostridium difficile and Bifidobacterium longum subsp. longum in co-culture analysed by flow cytometry. Novakova J; Džunková M; Musilova S; Vlkova E; Kokoska L; Moya A; D'Auria G J Med Microbiol; 2014 Dec; 63(Pt 12):1663-1669. PubMed ID: 25298160 [TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of the probiotic properties of human intestinal Bifidobacterium species and selection of new probiotic candidates. Delgado S; O'Sullivan E; Fitzgerald G; Mayo B J Appl Microbiol; 2008 Apr; 104(4):1119-27. PubMed ID: 18248372 [TBL] [Abstract][Full Text] [Related]
20. Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus. Collado MC; Jalonen L; Meriluoto J; Salminen S Asia Pac J Clin Nutr; 2006; 15(4):570-5. PubMed ID: 17077078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]